Cargando…

Immune complement activation is attenuated by surface nanotopography

The immune complement (IC) is a cell-free protein cascade system, and the first part of the innate immune system to recognize foreign objects that enter the body. Elevated activation of the system from, for example, biomaterials or medical devices can result in both local and systemic adverse effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulander, Mats, Lundgren, Anders, Berglin, Mattias, Ohrlander, Mattias, Lausmaa, Jukka, Elwing, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218579/
https://www.ncbi.nlm.nih.gov/pubmed/22114496
http://dx.doi.org/10.2147/IJN.S24578
_version_ 1782216700295380992
author Hulander, Mats
Lundgren, Anders
Berglin, Mattias
Ohrlander, Mattias
Lausmaa, Jukka
Elwing, Hans
author_facet Hulander, Mats
Lundgren, Anders
Berglin, Mattias
Ohrlander, Mattias
Lausmaa, Jukka
Elwing, Hans
author_sort Hulander, Mats
collection PubMed
description The immune complement (IC) is a cell-free protein cascade system, and the first part of the innate immune system to recognize foreign objects that enter the body. Elevated activation of the system from, for example, biomaterials or medical devices can result in both local and systemic adverse effects and eventually loss of function or rejection of the biomaterial. Here, the researchers have studied the effect of surface nanotopography on the activation of the IC system. By a simple nonlithographic process, gold nanoparticles with an average size of 58 nm were immobilized on a smooth gold substrate, creating surfaces where a nanostructure is introduced without changing the surface chemistry. The activation of the IC on smooth and nanostructured surfaces was viewed with fluorescence microscopy and quantified with quartz crystal microbalance with dissipation monitoring in human serum. Additionally, the ability of pre-adsorbed human immunoglobulin G (IgG) (a potent activator of the IC) to activate the IC after a change in surface hydrophobicity was studied. It was found that the activation of the IC was significantly attenuated on nanostructured surfaces with nearly a 50% reduction, even after pre-adsorption with IgG. An increase in surface hydrophobicity blunted this effect. The possible role of the curvature of the nanoparticles for the orientation of adsorbed IgG molecules, and how this can affect the subsequent activation of the IC, are discussed. The present findings are important for further understanding of how surface nanotopography affects complex protein adsorption, and for the future development of biomaterials and blood-contacting devices.
format Online
Article
Text
id pubmed-3218579
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-32185792011-11-23 Immune complement activation is attenuated by surface nanotopography Hulander, Mats Lundgren, Anders Berglin, Mattias Ohrlander, Mattias Lausmaa, Jukka Elwing, Hans Int J Nanomedicine Original Research The immune complement (IC) is a cell-free protein cascade system, and the first part of the innate immune system to recognize foreign objects that enter the body. Elevated activation of the system from, for example, biomaterials or medical devices can result in both local and systemic adverse effects and eventually loss of function or rejection of the biomaterial. Here, the researchers have studied the effect of surface nanotopography on the activation of the IC system. By a simple nonlithographic process, gold nanoparticles with an average size of 58 nm were immobilized on a smooth gold substrate, creating surfaces where a nanostructure is introduced without changing the surface chemistry. The activation of the IC on smooth and nanostructured surfaces was viewed with fluorescence microscopy and quantified with quartz crystal microbalance with dissipation monitoring in human serum. Additionally, the ability of pre-adsorbed human immunoglobulin G (IgG) (a potent activator of the IC) to activate the IC after a change in surface hydrophobicity was studied. It was found that the activation of the IC was significantly attenuated on nanostructured surfaces with nearly a 50% reduction, even after pre-adsorption with IgG. An increase in surface hydrophobicity blunted this effect. The possible role of the curvature of the nanoparticles for the orientation of adsorbed IgG molecules, and how this can affect the subsequent activation of the IC, are discussed. The present findings are important for further understanding of how surface nanotopography affects complex protein adsorption, and for the future development of biomaterials and blood-contacting devices. Dove Medical Press 2011 2011-10-31 /pmc/articles/PMC3218579/ /pubmed/22114496 http://dx.doi.org/10.2147/IJN.S24578 Text en © 2011 Hulander et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Hulander, Mats
Lundgren, Anders
Berglin, Mattias
Ohrlander, Mattias
Lausmaa, Jukka
Elwing, Hans
Immune complement activation is attenuated by surface nanotopography
title Immune complement activation is attenuated by surface nanotopography
title_full Immune complement activation is attenuated by surface nanotopography
title_fullStr Immune complement activation is attenuated by surface nanotopography
title_full_unstemmed Immune complement activation is attenuated by surface nanotopography
title_short Immune complement activation is attenuated by surface nanotopography
title_sort immune complement activation is attenuated by surface nanotopography
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218579/
https://www.ncbi.nlm.nih.gov/pubmed/22114496
http://dx.doi.org/10.2147/IJN.S24578
work_keys_str_mv AT hulandermats immunecomplementactivationisattenuatedbysurfacenanotopography
AT lundgrenanders immunecomplementactivationisattenuatedbysurfacenanotopography
AT berglinmattias immunecomplementactivationisattenuatedbysurfacenanotopography
AT ohrlandermattias immunecomplementactivationisattenuatedbysurfacenanotopography
AT lausmaajukka immunecomplementactivationisattenuatedbysurfacenanotopography
AT elwinghans immunecomplementactivationisattenuatedbysurfacenanotopography